In terms of mechanism, sorafenib blocks the import of cysteine by inhibiting SLC7A11, the subunit of cystine/glutamate antiporter system Xc−, thereby triggering ferroptosis and ultimately killing HCC cells (Louandre et al., 2013). Here, SLC7A11 is linked to hepatocellular carcinoma.